MedTrace Logo

Normobaric Hyperoxia Stabilizing Ischemic Penumbra

NCT05781880 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2023-04-19

No results posted yet for this study

Summary

To investigate the safety and efficacy of normobaric hyperoxia (NBO) stabilizing penumbra in acute ischemic stroke patients.

Conditions

  • Acute Ischemic Stroke

Interventions

OTHER

Oxygen 100%

NBO therapy were given 100% oxygen via a face mask (10L/min for 4h)

Sponsors & Collaborators

  • Ji Xunming,MD,PhD

    lead OTHER

Principal Investigators

  • Xunming Ji, MD · Xuanwu Hospital of Capital Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-22
Primary Completion
2024-11-30
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05781880 on ClinicalTrials.gov